![]() |
市场调查报告书
商品编码
1374801
全球视讯喉镜市场 -2023-2030Global Video Laryngoscopes Market -2023-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
视讯喉镜检查是间接喉镜检查的一种形式,其中临床医生不直接观察喉部。相反,喉部的可视化是透过经鼻或经口插入的光纤或数位喉镜进行的。
视讯喉镜 (VL) 利用摄影机技术来视觉化气道结构并促进气管插管 (ETI)。鑑于视讯技术的进步,市场上出现了更可靠、更强大、更便宜的视讯喉镜,并且可用性不断提高。
视讯喉镜在困难的气道管理场景中特别有利。它们可以更好地观察声门,更容易应对解剖结构变化、张口受限或因血液、分泌物或水肿而导致可视化不佳的情况。这有助于及时识别和解决气道挑战,降低併发症风险并提高病患安全。
喉癌盛行率的上升是预测期内帮助市场成长的重要关键驱动因素之一。一些常见的喉部疾病包括喉炎、声带小结、声带息肉、赖因克水肿和会厌囊肿等。此外,据观察,男性喉部疾病的盛行率较高。
例如,根据美国癌症协会估计,到 2023 年,美国将新增约 12,470 例喉癌病例(男性 9,990 例,女性 2,480 例)。约 60% 的喉癌始于声门(包含声带的区域),而约 35% 则发生于声门上区域(声带上方)。
喉镜检查采集声带或喉咙附近部分的活检样本,以进一步检测癌症。因此,喉部疾病盛行率的不断上升将加速全球喉镜市场的发展,并预计未来将继续成长,从而推动预测期内研究市场的成长。
此外,视讯喉镜市场受到多种因素的推动。此外,越来越多的出版物和研究表明这些设备相对于直接喉镜手术的安全性和优越性,以及市场参与者推出的创新产品,都有助于提高视讯喉镜的采用率。这些产品遍布全球。与基于推车的显示模型相比,整合视讯显示的便利性以及完全一次性设备(例如 Intersurgical Ltd 的「I-view」)的引入进一步增强了这种采用。
限制视讯喉镜市场成长的主要因素之一是麻醉视讯喉镜在新兴国家的采用率较低,因为其成本高且缺乏有利的报销政策来提供覆盖。根据美敦力的资料,可重复使用设备的成本根据其技术专业性从 1,050 美元到 8,050 百万美元不等,而一次性传统喉镜的成本为 1,850 万美元。
因此,这些设备的高成本及其维护预计将阻碍视讯喉镜市场。同时,具有成本效益的气管插管替代设备的可用性是视讯喉镜市场成长机会的主要限制因素。
Video laryngoscopy is a form of indirect laryngoscopy in which the clinician does not directly view the larynx. Instead, visualization of the larynx is performed with a fiberoptic or digital laryngoscope inserted transnasally or transorally.
Video laryngoscopy (VL) utilizes video camera technology to visualize airway structures and facilitate endotracheal intubation (ETI). Given the advances in video technology, more reliable, powerful, and less expensive video laryngoscopes are emerging on the market with increasing availability.
Video laryngoscopes can be particularly advantageous in difficult airway management scenarios. They offer a better view of the glottis, making it easier to navigate anatomical variations, limited mouth opening, or situations with poor visualization due to blood, secretions, or edema. This can help in identifying and addressing airway challenges promptly, reducing the risk of complications and improving patient safety.
The rise in the prevalence of laryngeal cancer is one of the significant key drivers that helps the market to grow during the forecast period. Some common laryngeal diseases include laryngitis, vocal nodules, vocal polyps, Reinke's edema, and epiglottic cyst, among others. In addition, it has been observed that the prevalence of laryngeal disease is higher in males.
For instance, according to the American Cancer Society, it estimates in 2023, there will be about 12,470 new cases of laryngeal cancer (9,990 in men and 2,480 in women) in the United States. About 60% of laryngeal cancers start in the glottis (the area containing the vocal cords), while about 35% develop in the supraglottic area (above the vocal cords).
Laryngoscopy takes biopsy samples of the vocal cords or nearby parts of the throat to detect cancer further. Thus, the increasing prevalence of laryngeal disease is poised to accelerate the laryngoscope market globally and is expected to increase in the future, thereby driving the growth of the market studied over the forecast period.
Furthermore, the video laryngoscope market is driven by various factors Also, the growing publications and studies indicating the safety and superiority of these devices over direct laryngoscopy procedures, along with the introduction of innovative products by market players, have been instrumental in the higher adoption of these products globally. This adoption is further augmented by the facilitation of an integrated video display, as opposed to cart-based display models, and the introduction of fully disposable devices such as the "I-vieW' by Intersurgical Ltd.
One of the major factors limiting the growth of the video laryngoscope market is the lower adoption of anaesthesia video laryngoscopes in emerging countries due to their high cost and a lack of favourable reimbursement policies to provide coverage. According to Medtronic data, the cost of reusable devices ranges from USD 1,050 to USD 8,050 Mn depending on their technical speciality, compared to the cost of a single-use traditional laryngoscope, which is USD 18.5 Mn.
As a result, the high cost of these devices, as well as their maintenance, are expected to hamper the video laryngoscope market. At the same time, the availability of cost-effective alternate devices for endotracheal intubation is a major restraining factor for the video laryngoscope market growth opportunities.
The global video laryngoscopes is segmented based on device type, usage, channel type, end-user and region.
The flexible video laryngoscope segment from the device type segment accounted for 41.2% and it is expected to be dominated during the forecast period. It enables the user to visualize biopsy tissue, and abnormalities, or aid in the removal of small growths, such as polyps, from the region, thus propelling growth. The additional advantage is that the camera can be precisely manipulated, enabling the doctor a clear and complete view of the motion of the vocal cords. These factors are expected to drive the segment growth over the forecast period.
For instance, in April 2023, Verathon, a global leader in airway management solutions, announced the launch of the GlideScope Spectrum QC with QuickConnect technology. This new, extensive portfolio of single-use video laryngoscopes features a unique, magnetic connector coupled with image quality enhancements to support fast, effective airway management.
The new Spectrum QC operates seamlessly with Verathon's GlideScope Core™ visualization system, the most comprehensive and flexible airway visualization system for video laryngoscopy, bronchoscopy, and dual-view airway procedures.
North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to the higher adoption rate of advanced devices, collaborations with key players, novel product launches in emerging markets greater affordability among patients, developed healthcare infrastructure, and constant focus of market players on the U.S
For instance, in June 2023, Teleflex Incorporated a leading global provider of medical technologies, announced a partnership with Shenzhen Insighters Medical Technology Co., Ltd. As the exclusive U.S. distributor of the Insighters Video Laryngoscope system, which is designed to inspect the upper glottic airway and facilitate endotracheal intubation.
Moreover, in July 2020, Nihon Kohden, a U.S. market leader in precision medical products and services, announced that it is offering the NK AWS-S200 video laryngoscope as part of its critical care portfolio. Designed for the safe and secure intubation of patients in even the most difficult situations, the NK AWS-S200 may reduce the exposure to aerosolized particles ii, which can help protect clinicians while intubating patients suffering from COVID-19 or other respiratory infections.
The COVID-19 pandemic brought the video laryngoscope increasingly into mainstream anaesthetic practice. This is a prime opportunity to consolidate the newfound resources and expertise by using a video laryngoscope as a routine intubation device for all patients. Skills degrade over time; therefore, routine use of video laryngoscopes could enable skill maintenance and reinforcement.
The major global players in the Video Laryngoscopes market include: Medtronic Plc, Ambu A/S, Flexicare Group Limited, KARL STORZ SE & Co., Verathon Inc., Nihon Kohden Corporation, Intersurgical Ltd, Hebei Vimed Medical Device Company, Ltd., Infinium Medical, VDO Medical Inc and among others.
The global video laryngoscopes market report would provide approximately 69 tables, 70 figures, and 185 Pages.
LIST NOT EXHAUSTIVE